Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-18

Clinical Trial Update: Study of CYR-064 Versus Placebo in Patients. [Phase 2]

View source ↗

Summary

This update notes the completion of a Phase 2 trial of CYR-064 versus placebo in hyposmia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYR-064

Snippet

Sponsor: Cyrano Therapeutics, Inc. | Conditions: Hyposmia | Phase 2 | Status: COMPLETED